Pharvaris PHVS
NASDAQ PHVS
$31.73 -0.18 (-0.56%)
At close: Sep 29, 2026 · 4:00 PM EDT

Pharvaris (PHVS) Deferred Taxes (2021 - 2024)

Updated

Pharvaris (PHVS) recorded Deferred Taxes of -$2.45 million in FY2025, compared with -$3 million in FY2024.

Analysis

Pharvaris (PHVS) Deferred Taxes (2021 - 2024) Analysis & Trends

Starting with FY2021, Pharvaris' Deferred Taxes history includes 5 years.

  • Annual Deferred Taxes has ranged from -$3 million in FY2024 to -$32,680 in FY2021 over the past five years.
  • Per Business Quant data, PHVS's Deferred Taxes was -$3 million in FY2024, -$1.2 million in FY2023, -$192,688 in FY2022 and -$32,680 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -479.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -195.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -587.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Pharvaris 2.08 Bn -289,124.32 Bn 85,072.10 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -445,296.53
Sep 30, 2024 1,224.25 Bn
Jun 30, 2024 -1,200.47 Bn
Mar 31, 2024 -65,184.97
Dec 31, 2023 -298,941.30
Sep 30, 2023 417.97 Bn
Jun 30, 2023 -415.62 Bn
Mar 31, 2023 -2.44 Bn
Dec 31, 2022 17,565.60
Sep 30, 2022 -201,696.21
Dec 31, 2021 620.03
Sep 30, 2021 -1,252.40
API Access

Pharvaris Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=PHVS&period=max&api_key=YOUR_API_KEY